FEB 12, 2016 02:58 PM PST

Reprogramming Naive T Cells to Attack Cancerous B Cells

WRITTEN BY: Kara Marker
Acute lymphoblastic leukemia (ALL) and non-Hodgkin’s Lymphoma (NHL) affect 75,000 and 72,000 people each year in the United States, respectively. In addition to immunotherapy, chemotherapy, radiation, and stem cell transplants are a few treatments used to fight these cancers, but thousands of Americans still die every year.
 
A new study from the Children’s Hospital of Philadelphia (CHOP) provides promising new findings to improve current chemotherapies for pediatric cancer. Together with the Perelman School of Medicine at the University of Pennsylvania, CHOP researchers identified a specific sub-type of T lymphocytes to use for immunotherapy: the youngest cells.
 

 
Young T lymphocytes, characterized either as naïve cells or stem central memory cells, both expanded successfully in the lab and proved to be most efficient in attacking cancerous cells. The study was published last month in Science Translational Medicine.
 
The team of researchers observed 50 patients; all were either children or teenagers with B cell cancers. 38 of the 50 had ALL and 12 had NHL. By monitoring their T lymphocyte count every month for six months, the researchers were able to see positive change in the new immunotherapy using young T lymphocytes.
 
The therapy works by first taking out the patient’s T lymphocytes, tuning them to specifically find and kill cancerous B cells, and then returning them to the patient so they can work.
 
In the words of one of the study leaders, David M. Barrett, MD, PhD, "Collecting and expanding these cells could increase the number of children with cancer who could benefit from this innovative treatment."
 
Despite the clear success in the younger cells’ ability to kill cancer cells, they were also uniquely susceptible to chemotherapy, much more so than older T lymphocytes. In order to avoid elimination by chemicals from chemotherapy, which is almost always used in conjunction with immunotherapy at some point during cancer treatment, the researchers agreed that the young T lymphocytes would have to be extracted before any chemotherapy is administered.
 
"We could keep the patient's early-lineage T cells in reserve, in case the patient needs them later,” Barrett said.
 
Although the immunotherapy with young T lymphocytes showed increased success in treating both ALL and NHL patients, ALL patients saw greater success because they had more young T lymphocytes to collect from than NHL patients. Thus, the fight against B cell cancers is far from over.
 
 
Source: Children’s Hospital of Philadelphia
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAY 02, 2018
Immunology
MAY 02, 2018
Photographing the Measles Virus
The measles virus was caught leaving infected cells by the scientific paparazzi, that is, experts from Emory Health Sciences using cryo-electron tomography...
MAY 24, 2018
Immunology
MAY 24, 2018
The Link Between Tuberculosis and Parkinson Disease
There might be a link between Tuberculosis (TB) and Parkinson’s according to a study published in The EMBO Journal. This link is related to the mecha...
JUN 01, 2018
Immunology
JUN 01, 2018
How does estrogen increase the risk of autoimmunity for women?
The unique activity of estrogen hormones and their cell receptors in the female body may explain why women are more likely than men to develop autoimmune d...
JUN 20, 2018
Immunology
JUN 20, 2018
Immune System Accidentally Allows Meningitis Brain Infection
Several immune cells help fungi infect the brain and cause meningitis when they should be doing the exact opposite. From the University of Sydney, research...
AUG 29, 2018
Immunology
AUG 29, 2018
Immune System Prioritizes Response when Faced with Multiple Threats
The Innate Immune response prioritizes lung infection and cell repair over other threats in both infants and adults....
SEP 11, 2018
Cannabis Sciences
SEP 11, 2018
The Potential Anti-cancer Effects of Cannabinoids
They're known for helping to reduce the impact of cancer drug side effects, but it's possible that cannabinoids themselves are cancer fighters....
Loading Comments...